Disse data tyder på, at CANCIDAS kan anvendes hos patienter, der behandles med ciclosporin, hvis de potentielle fordele overstiger de potentielle risici.
These data suggest that CANCIDAS can be used in patients receiving cyclosporin when the potential benefit outweighs the potential risk.